Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA.
Mol Genet Metab. 2013 Aug;109(4):319-28. doi: 10.1016/j.ymgme.2013.05.008. Epub 2013 May 23.
A trans-National Institutes of Health initiative, Nutrition and Dietary Supplement Interventions for Inborn Errors of Metabolism (NDSI-IEM), was launched in 2010 to identify gaps in knowledge regarding the safety and utility of nutritional interventions for the management of inborn errors of metabolism (IEM) that need to be filled with evidence-based research. IEM include inherited biochemical disorders in which specific enzyme defects interfere with the normal metabolism of exogenous (dietary) or endogenous protein, carbohydrate, or fat. For some of these IEM, effective management depends primarily on nutritional interventions. Further research is needed to demonstrate the impact of nutritional interventions on individual health outcomes and on the psychosocial issues identified by patients and their families. A series of meetings and discussions were convened to explore the current United States' funding and regulatory infrastructure and the challenges to the conduct of research for nutritional interventions for the management of IEM. Although the research and regulatory infrastructure are well-established, a collaborative pathway that includes the professional and advocacy rare disease community and federal regulatory and research agencies will be needed to overcome current barriers.
一个跨国立卫生研究院的倡议,即营养和膳食补充剂干预先天性代谢缺陷(NDSI-IEM),于 2010 年启动,旨在确定在管理先天性代谢缺陷(IEM)方面,营养干预的安全性和实用性方面存在的知识空白,这些空白需要用循证研究来填补。IEM 包括遗传性生化障碍,其中特定的酶缺陷会干扰外源性(饮食)或内源性蛋白质、碳水化合物或脂肪的正常代谢。对于其中一些 IEM,有效的管理主要依赖于营养干预。需要进一步研究来证明营养干预对个体健康结果以及患者及其家属确定的心理社会问题的影响。为了探索目前美国在管理 IEM 的营养干预方面的研究的资金和监管结构以及所面临的挑战,举行了一系列会议和讨论。虽然研究和监管结构已经建立得很好,但需要一个包括专业和倡导罕见病社区以及联邦监管和研究机构的合作途径,以克服当前的障碍。